Medicine Overview
Adult Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Allergic conditions; Treatment and prophylaxis of motion sickness Age: Adult |
Dose: Oral – 25-50 mg Frequency: 3-4 times daily Note: For prevention of motion sickness, administer 30 minutes before exposure to motion. Maximum: 300 mg daily. Hepatic impairment: No dosage adjustment needed. |
|
Indication: Parkinson's disease Age: Adult |
Dose: Oral – Initially, 25 mg Frequency: three times daily Note: May increase to 50 mg 4 times daily if necessary. Hepatic impairment: No dosage adjustment needed. |
Child Dose
| Clinical Information | Administration Information |
|---|---|
|
Indication: Allergic Reaction Age: 2-6 years |
Dose: by mouth (oral) – 6.25 mg Frequency: every 4-6 hours Note: not to exceed 37.5 mg/day |
|
Indication: Allergic Reaction Age: 6-12 years |
Dose: by mouth (oral) – 12.5-25 mg Frequency: every 4-6 hours Note: not to exceed 150 mg/day |
Renal Dose
| Clinical Information | Administration Information |
|---|---|
|
Condition: Renal impairment |
Dose: Form – Not specified Note: No dosage adjustment needed. |
Administration
- Take with or without food
- May cause drowsiness
Side Effect
- Chest tightness
- extrasystoles
- hypotension
- palpitations
- tachycardia
- ataxia
- chills
- confusion
- dizziness
- drowsiness
- euphoria
- excitement
- fatigue
- headache
- insomnia
- irritability
- nervousness
- neuritis
- paraesthesia
- paradoxical excitation
- restlessness
- sedation
- seizure
- vertigo
- diaphoresis
- menstrual disease
- GI disturbances (eg anorexia
- constipation
- diarrhoea)
- difficulty in micturition
- urinary frequency
- urinary retention
- agranulocytosis
- haemolytic anaemia
- thrombocytopenia
- anaphylactic shock
- tremor
- blurred vision
- diplopia
- acute labyrinthitis
- tinnitus
- constriction of pharynx
- nasal congestion
- thickening of bronchial secretions
- wheezing
Drug Interaction
Drug Interaction
| Drug Name | Risk Factors |
|---|---|
|
Aminoglycosides
|
Masks ototoxicity
|
|
Levodopa
|
Increases gastric degradation and decreases absorption
|
Disease Interaction
Disease Interaction
| Disease Name | Risk Factors |
|---|---|
|
Not available
|
Not available
|
Pregnancy
Pregnancy
Lactation
Special Use
Precaution
Overdose
Pharmacology
Storage
Store between 15-30° C. Protect from moisture.
Data Sources
Clinical & regulatory information on this page is compiled from the following government sources:
DISCLAIMER: This drug information content is provided for informational purposes only and is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Patients should always consult their physician with any questions regarding a medical condition and to obtain medical advice and treatment.